Profound Medical Corp PROF

Primary Symbol: T.PRN

Healthcare Medical Devices

Profound Medical Corp. is a Canada-based commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), robotically driven transurethral ultrasound and closed-loop temperature feedback control. The TULSA procedure, performed using the TULSA-PRO system, has the potential of becoming a mainstream treatment modality across the entire prostate disease spectrum; ranging from low -, intermediate-, or high-risk prostate cancer; to hybrid patients suffering from both prostate cancer and benign prostatic hyperplasia (BPH); to men with BPH only; and also, to patients requiring salvage therapy for radio-recurrent localized prostate cancer. It is also commercializing Sonalleve, a therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases.

TSX:PRN - Post by User

Profound Medical Corp

<< Previous

Bullboard Posts

Next >>

Post by HomerAndCompanyon Sep 18, 2021 8:32am

283 Views

Post# 33882882

Profound to Double Size of Sales & Installation Teams by Q4

As per the Q2 conference call Aug4, 2021. So we should see a faster rate of new installations as well as more treatments per site at existing installations accelerating PRN on the path to profitability.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing